Evaluation of four pyridine analogs to characterize 6-OHDA-induced modulation of mGluR5 function in rat brain using microPET studies. (Q48273518)

10 February 2018

title

Evaluation of four pyridine analogs to characterize 6-OHDA-induced modulation of mGluR5 function in rat brain using microPET studies. (English)

1 reference

10 February 2018

author name string

Aijun Zhu

1

1 reference

10 February 2018

Xukui Wang

2

1 reference

10 February 2018

Meixiang Yu

3

1 reference

10 February 2018

Ji-Quan Wang

4

1 reference

10 February 2018

Anna-Liisa Brownell

5

1 reference

10 February 2018

publication date

14 February 2007

1 reference

10 February 2018

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

10 February 2018

volume

27

1 reference

10 February 2018

issue

9

1 reference

10 February 2018

page(s)

1623-1631

1 reference

10 February 2018

Functional and molecular characterization of metabotropic glutamate receptors expressed in rat striatal cholinergic interneurones

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Animal models of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Membrane topology of a metabotropic glutamate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Interactions of the mGluR5 gene with breeding and maternal factors on startle and prepulse inhibition in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Pharmacology and functions of metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

[3H]-methoxymethyl-MTEP and [3H]-methoxy-PEPy: potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Distribution volume ratios without blood sampling from graphical analysis of PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Graphical analysis of PET data applied to reversible and irreversible tracers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Glutamate receptors and Parkinson's disease: opportunities for intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Presynaptic group I and II metabotropic glutamate receptors oppositely modulate striatal acetylcholine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Mechanisms of action of 6-hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

The mGluR5 selective antagonist 6-methyl-2-(phenylethynyl)-pyridine reduces the spinal neuron pain-related activity in mononeuropathic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

6-hydroxy-dopamine induced degeneration of central monoamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Statistics review 5: Comparison of means

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Methoxyphenylethynyl, methoxypyridylethynyl and phenylethynyl derivatives of pyridine: synthesis, radiolabeling and evaluation of new PET ligands for metabotropic glutamate subtype 5 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Dose-dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

7 January 2021

Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

7 January 2021

Metabotropic glutamate receptors are differentially regulated during development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

7 January 2021

Quantitation in positron emission computed tomography: 1. Effect of object size

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

7 January 2021

Interaction between metabotropic and ionotropic glutamate receptors regulates neuronal network activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

7 January 2021

Glutamate as a neurotransmitter in the brain: review of physiology and pathology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

7 January 2021

Fibroblast growth factor-2-producing fibroblasts protect the nigrostriatal dopaminergic system from 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

7 January 2021

Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600461

7 January 2021

Identifiers

DOI

10.1038/SJ.JCBFM.9600461

1 reference

10 February 2018

1 reference

10 February 2018